Entera Bio Ltd. (ENTX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $7.11M | -17.9% |
| 2024 | $8.66M | -21.4% |
| 2023 | $11.02M | -10.5% |
| 2022 | $12.31M | -50.6% |
| 2021 | $24.89M | +189.7% |
| 2020 | $8.59M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $7.11M | -17.9% |
| 2024 | $8.66M | -21.4% |
| 2023 | $11.02M | -10.5% |
| 2022 | $12.31M | -50.6% |
| 2021 | $24.89M | +189.7% |
| 2020 | $8.59M | — |